GIGALANE: Q1 2026 Operating Loss Widens; Stock Consolidation Approved

Consolidated Q1 2026 revenue: 7,813M KRW (+14.7% YoY from 6,809M), operating loss: 4,717M KRW (loss widened from 2,974M loss in Q1 2025).
Net loss attributable to parent: 3,965M KRW (vs 2,925M loss), basic EPS loss: 41 KRW (vs 34 KRW loss).
Separate revenue: 8,345M KRW, operating loss: 3,090M KRW, net loss: 2,320M KRW.
Stock consolidation approved: par value from 500 KRW to 5,000 KRW, shares from 84,883,347 to 8,488,334 (10:1). Goal: adjust floating shares and stabilize stock price. EGM on May 11, effective June 12, expected listing June 29.
Consolidated debt ratio: 129.8% (FY2025: 119.5%), net debt ratio: 50.3% (FY2025: 46.7%), financial leverage increased.
R&D expenses: 1,313M KRW (16.8% of sales vs 13.8% in FY2025), continued investment.
No dividend, share buyback or cancellation plans.
No pending litigation.